일신바이오
Financials
Valuation Metrics
일신바이오's Market Cap is ₩461B. At end of 2025 it was ₩712B. Ranked #1816 of 2,421 in KR market (top 75%), #1112 of 1,640 on KOSDAQ (top 68%), #298 of 361 in Capital Goods (top 83%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 46.07B KRW | KR#1,816/2,421 Sec#298/361 |
| Revenue | 15.79B KRW | KR#2,204/2,421 Sec#338/361 |
| Net Income | 6.01B KRW | KR#1,140/2,421 Sec#185/361 |
| Total Assets | 68.58B KRW | KR#2,022/2,421 Sec#327/361 |
| Net Assets | 64.80B KRW | KR#1,736/2,421 Sec#282/361 |
| Employees | 37 | KR#2,154/2,421 Sec#324/361 |
| Value | ||
| P/E | 7.66x | KR#632/2,421 Sec#93/361 |
| P/B | 0.71x | KR#1,143/2,421 Sec#152/361 |
| PEG | 0.14x | KR#476/2,421 Sec#69/361 |
| P/S | 2.92x | KR#1,974/2,421 Sec#294/361 |
| EV/EBITDA | 8.89x | KR#541/2,421 Sec#75/361 |
| FCF Yield | 11.42% | KR#556/2,421 Sec#84/361 |
| Profitability | ||
| ROE | 9.28% | KR#670/2,421 Sec#112/361 |
| ROA | 8.77% | KR#364/2,421 Sec#56/361 |
| Op. Margin | 31.42% | KR#53/2,421 Sec#5/361 |
| Revenue Growth | 32.31% | KR#359/2,421 Sec#57/361 |
| Earnings Growth | 56.48% | KR#523/2,421 Sec#78/361 |
| Financial Health | ||
| Debt Ratio | 5.85% | KR#46/2,421 Sec#3/361 |
| Total Debt | 0 KRW | KR—/2,421 Sec—/361 |
| FCF | 5.26B KRW | KR#892/2,421 Sec#142/361 |
| Cash | 1.98B KRW | KR#2,250/2,421 Sec#341/361 |
| Net Debt/EBITDA | -0.40x | KR#519/2,421 Sec#62/361 |
| Dividend | ||
| Div. Yield | 0.96% | KR#1,131/2,421 Sec#166/361 |
| Div. Growth | 42.86% | KR#277/2,421 Sec#58/361 |
| Performance | ||
| 1Y Return | -39.42% | KR#1,818/2,421 Sec#291/361 |
| 1M Return | 6.33% | KR#668/2,421 Sec#131/361 |
| From 52W High | -49.29% | KR#1,363/2,421 Sec#186/361 |
| 1Y MDD | -53.40% | KR#1,144/2,421 Sec#146/361 |
| Trading | ||
| Volume | 64,076 shares | KR#1,006/2,421 Sec#195/361 |
| Trading Value | 67.8M KRW | KR#1,723/2,421 Sec#292/361 |
| Foreign Own. | 3.05% | KR#1,274/2,421 Sec#210/361 |
| Per Share | ||
| EPS | 136 KRW | KR#1,377/2,421 Sec#217/361 |
| BPS | 1,465 KRW | KR#2,203/2,421 Sec#343/361 |
Company Info
Established in 1988 and converted to a corporation in 1994, the company was listed on KOSDAQ in 2007 and changed its name to Ilshinbiobase in 2009. It specializes in bio-equipment, manufacturing, selling, and exporting research equipment like lyophilizers for biotechnology research and ultra-low temperature freezers, alongside large industrial lyophilizers. Leveraging vacuum, refrigeration, and control technologies, the company offers a diverse product lineup and pursues growth by developing high-performance automatic control systems and expanding global GMP-compliant models. Ilshinbio is headquartered in Dongducheon-si, Gyeonggi-do.